Total Payments
$45,324
2024 Payments
$4,012
Companies
86
Transactions
1,439
Medicare Patients
616
Medicare Billing
$66,683
Payment Breakdown by Category
Food & Beverage$29,632 (65.4%)
Other$10,400 (22.9%)
Consulting$3,450 (7.6%)
Travel$1,639 (3.6%)
Education$143.60 (0.3%)
Gifts$59.40 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,632 | 1,419 | 65.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,400 | 5 | 22.9% |
| Consulting Fee | $3,450 | 1 | 7.6% |
| Travel and Lodging | $1,639 | 5 | 3.6% |
| Education | $143.60 | 8 | 0.3% |
| Gift | $59.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $14,469 | 112 | $0 (2024) |
| Acerus Pharmaceuticals Corporation | $4,187 | 6 | $0 (2022) |
| Abbott Laboratories | $3,113 | 55 | $0 (2024) |
| ABBVIE INC. | $2,224 | 123 | $0 (2024) |
| Lilly USA, LLC | $2,153 | 142 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,300 | 55 | $0 (2024) |
| Novo Nordisk Inc | $1,238 | 70 | $0 (2024) |
| Amgen Inc. | $1,220 | 66 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,093 | 63 | $0 (2024) |
| Biosense Webster, Inc. | $1,077 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,012 | 157 | AstraZeneca Pharmaceuticals LP ($425.83) |
| 2023 | $3,249 | 148 | ABBVIE INC. ($505.81) |
| 2022 | $8,210 | 186 | Acerus Pharmaceuticals Corporation ($4,187) |
| 2021 | $3,747 | 179 | Abbott Laboratories ($467.43) |
| 2020 | $2,739 | 138 | Abbott Laboratories ($435.07) |
| 2019 | $3,182 | 172 | Abbott Laboratories ($532.13) |
| 2018 | $5,592 | 168 | Janssen Pharmaceuticals, Inc ($3,014) |
| 2017 | $14,593 | 291 | Janssen Pharmaceuticals, Inc ($10,020) |
All Payment Transactions
1,439 individual payment records from CMS Open Payments — Page 3 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Insomnia | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Oncology | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: PAIN | ||||||
| 07/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: Cardio-renal | ||||||
| 07/24/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $148.11 | General |
| Category: Cardiovascular Device | ||||||
| 07/24/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/22/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Insomnia | ||||||
| 07/19/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: Cardiology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 182 | 224 | $35,134 | $18,194 |
| 2022 | 3 | 156 | 231 | $32,294 | $17,590 |
| 2021 | 3 | 149 | 201 | $31,041 | $17,946 |
| 2020 | 4 | 129 | 164 | $27,314 | $12,953 |
Total Patients
616
Total Services
820
Medicare Billing
$66,683
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 124 | $14,260 | $7,335 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $12,762 | $6,739 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 48 | $8,112 | $4,120 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 140 | $16,100 | $8,738 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 77 | $13,013 | $7,000 | 53.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $3,181 | $1,852 | 58.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 113 | $12,995 | $7,641 | 58.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $10,103 | $5,544 | 54.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 47 | $7,943 | $4,762 | 60.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 34 | 34 | $8,530 | $4,013 | 47.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 80 | $9,200 | $3,542 | 38.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 36 | $6,084 | $2,973 | 48.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 14 | 14 | $3,500 | $2,424 | 69.3% |
About Dr. James Hahn, MD
Dr. James Hahn, MD is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457330292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Hahn, MD has received a total of $45,324 in payments from pharmaceutical and medical device companies, with $4,012 received in 2024. These payments were reported across 1,439 transactions from 86 companies. The most common payment nature is "Food and Beverage" ($29,632).
As a Medicare-enrolled provider, Hahn has provided services to 616 Medicare beneficiaries, totaling 820 services with total Medicare billing of $66,683. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 01/11/2006
- Last Updated 11/15/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457330292
Products in Payments
- XARELTO (Drug) $14,192
- Natesto (Drug) $4,251
- JARDIANCE (Drug) $1,718
- CARTO 3 (Device) $1,077
- XIFAXAN (Drug) $1,035
- VRAYLAR (Drug) $996.18
- Ensite Cardiac Mapping System (Device) $828.19
- FARXIGA (Drug) $784.76
- Vascepa (Drug) $678.17
- MOUNJARO (Drug) $542.17
- LINZESS (Drug) $540.65
- Livalo (Drug) $503.84
- Optimizer (Device) $498.10
- EnSite Precision Cardiac Mapping System (Device) $467.43
- UBRELVY (Drug) $467.40
- REXULTI (Drug) $453.97
- TRULICITY (Drug) $449.95
- Omnilink Elite vascular stent system (Device) $433.82
- Edarbi (Drug) $421.87
- Kerendia (Drug) $421.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768
Geoffrey Cox, M.d, M.D
Family Medicine — Payments: $30,020
Family Medicine $30,020